MRI of normal and pathologic skeletal muscle

Area of Science:

• Biomedical Imaging
• Neuromuscular Diseases
• Skeletal Muscle Physiology

Background:

• Magnetic resonance imaging (MRI) is a non-invasive technique for visualizing soft tissues.
• Phosphorus-31 spectroscopy (³¹P spectroscopy) provides metabolic information about muscle tissue.
• Accurate localization of spectroscopy is essential for reliable metabolic data in muscle disorders.

Purpose of the Study:

• To evaluate the utility of MRI in characterizing lower extremity skeletal muscle abnormalities in patients with various neuromuscular diseases.
• To demonstrate the importance of muscle proton mapping using MRI to guide phosphorus-31 spectroscopy.
• To correlate MRI findings with clinical diagnoses of muscular and neuromuscular disorders.

Main Methods:

• Axial spin-echo MRI sequences with short repetition times (TR) and echo times (TE) were used.
• MRI was performed on 22 individuals: 5 healthy volunteers and 17 patients with diagnosed neuromuscular conditions.
• Diseases studied included Duchenne muscular dystrophy, limb-girdle muscular dystrophy, facioscapulohumeral dystrophy, and spinal muscular atrophy, among others.

Main Results:

• MRI provided excellent contrast between fat and muscle tissue, highlighting abnormalities.
• Common MRI findings across different neuromuscular diseases included altered muscle size and fat infiltration.
• Significant variability in muscle abnormality patterns was observed within and between disease groups.

Conclusions:

• Muscle proton mapping via MRI is valuable for identifying normal and abnormal muscle distribution in neuromuscular diseases.
• Integrating MRI proton maps with phosphorus-31 spectroscopy ensures that metabolic data is acquired from relevant muscle volumes.
• This approach enhances the diagnostic accuracy and clinical utility of phosphorus-31 spectroscopy in evaluating muscle dysfunction.